BioWorld MedTech

Feb. 19, 2019

View Archived Issues

FDA establishes new interoperable insulin pump device class – with Tandem up first

Tandem Diabetes Care Inc. saw its shares climb almost 20 percent this week, just as it became the first company to have a product classified in a new FDA category: Alternate Controller Enabled Infusion Pumps (ACE pumps). Read More

IBM shines at HIMSS with news of collaborations

Read More

Advisory panel says mesh should be superior to repair out to 36 months

Read More

India includes more med tech under existing law as it gears up for new framework

Read More

US, UK ink deal that protects trade regardless of Brexit outcome

Read More

Holiday notice

Read More

Appointments and advancements

Read More

Financings

Read More

Regulatory front

Read More

BioWorld MedTech stock report for public med-tech companies

Read More

Product briefs

Read More

Other news to note

Read More

BioWorld MedTech's Cardiology Extra

Read More